Panacea Announces Letter of Intent to Acquire N7 Enterprises, Inc.
January 23, 2023 09:15 ET
|
Panacea Life Sciences Holdings, Inc.
GOLDEN, Colo., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH) (“Panacea or PLSH” or the “Company”), a Colorado-based manufacturing, research and product...
Revolutionary progress made in the inaugural year of the Panacea Cannabinoid Research Center at Colorado State University
October 26, 2022 11:57 ET
|
Panacea Life Sciences Holdings, Inc.
GOLDEN, Colo., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) (“Panacea” or the “Company”), a Colorado, USA-based cannabinoid research and certified GMP...
Panacea awarded eight nutraceutical purchase orders as it expands its U.S. based softgel manufacturing services into the growing health, plant-based market
August 17, 2022 12:45 ET
|
Panacea Life Sciences Holdings, Inc.
GOLDEN, Colo., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH) (“Panacea” or the “Company”), a Colorado, USA-based cannabinoid research-focused company providing...
Panacea Life Sciences Announces Launch of CBDA Oil Drops as Potential Complementary Treatment for Long COVID
July 14, 2022 07:00 ET
|
Panacea Life Sciences Holdings, Inc.
GOLDEN, Colo., July 14, 2022 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH) (“Panacea” or the “Company”), a Colorado, USA-based cannabinoid research-focused company providing...